$330 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 8 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HRTX | Buy | HERON THERAPEUTICS INC | $161,746,000 | +126.0% | 5,190,837 | +5.5% | 49.08% | +28.9% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $65,318,000 | +66.4% | 2,664,970 | +24.3% | 19.82% | -5.1% |
| BRLI | New | BIO-REFERENCE LABS INC | $37,125,000 | – | 900,000 | +100.0% | 11.26% | – |
| OPKO HEALTH INCdebt 3.0% 2/1/33 | $33,131,000 | +12.5% | 14,000,000 | 0.0% | 10.05% | -35.8% | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $24,935,000 | +9.8% | 182,300 | 0.0% | 7.57% | -37.4% | |
| Sell | MERRIMACK PHARMACEUTICALS INCnote 4.5% 7/15/20 | $7,328,000 | -34.3% | 3,500,000 | -36.4% | 2.22% | -62.5% | |
| RXII | Exit | RXI PHARMACEUTICALS CORP | $0 | – | -1,572,699 | -100.0% | -0.60% | – |
| OGXI | Exit | ONCOGENEX PHARMACEUTICALS INC | $0 | – | -628,400 | -100.0% | -0.72% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -388,543 | -100.0% | -6.06% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERON THERAPEUTICS INC | 37 | Q3 2023 | 55.0% |
| LA JOLLA PHARMACEUTICAL CO | 34 | Q2 2022 | 37.1% |
| ROCKET PHARMACEUTICALS INC | 20 | Q3 2023 | 31.6% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2017 | 12.1% |
| ODONATE THERAPEUTICS INC | 17 | Q4 2021 | 69.8% |
| ANAPTYSBIO INC | 16 | Q3 2023 | 18.4% |
| COHERUS BIOSCIENCES INC | 15 | Q3 2023 | 2.7% |
| EQUILLIUM INC | 13 | Q3 2023 | 1.2% |
| RELMADA THERAPEUTICS INC | 12 | Q4 2022 | 6.2% |
| MIRATI THERAPEUTICS INC | 11 | Q3 2023 | 10.9% |
View TANG CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 4 | 2024-02-02 |
| 4 | 2023-12-18 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-13 |
| 13F-HR | 2023-08-14 |
| 3 | 2023-06-01 |
| 4 | 2023-06-01 |
| 4 | 2023-05-30 |
View TANG CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.